 RO-3306 synchronized >95% of cycling cells (including cancer cells), and released cells rapidly enter mitosis.Roscovitine can be used to inhibit the activity of cyclin-dependent kinases (CDKs) by competing with ATP in the ATP-binding region of the kinase.Its effects are potent, arresting cells by knocking down the function of CDKs necessary for cell cycle progression.